Commitments and contingencies - Additional Information (Details) - USD ($) $ in Millions |
1 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2024 |
May 31, 2024 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Loss Contingencies [Line Items] | ||||
| Preferred stock, shares issued | 0 | 78,762,142 | ||
| Clinical and regulatory milestone payments | $ 200.0 | |||
| Maximum | ||||
| Loss Contingencies [Line Items] | ||||
| Commercial milestone payments | $ 5,700.0 | |||
| Series A-2 Convertible Preferred Stock | ||||
| Loss Contingencies [Line Items] | ||||
| Preferred stock, shares issued | 5,677,603 | |||
| License and collaboration agreement | ||||
| Loss Contingencies [Line Items] | ||||
| Non-refundable upfront payment | $ 100.0 | |||
| Technology transfer fee | $ 10.0 | |||
| X | ||||||||||
- Definition Clinical and regulatory milestone payments. No definition available.
|
| X | ||||||||||
- Definition Commercial milestone payments. No definition available.
|
| X | ||||||||||
- Definition Non refundable upfront payment in cash. No definition available.
|
| X | ||||||||||
- Definition Technology transfer fee. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|